Literature DB >> 7764910

Biopharmaceutical R&D success rates and development times. A new analysis provides benchmarks for the future.

M M Struck1.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7764910     DOI： 10.1038/nbt0794-674

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN： 0733-222X


× No keyword cloud information.
  4 in total

Review 1.  Call for a new approach to the process of clinical trials and drug registration.

Authors:  T C Jones
Journal:  BMJ       Date:  2001-04-14

2.  Formation and isolation of spherical fine protein microparticles through lyophilization of protein-poly(ethylene glycol) aqueous mixture.

Authors:  T Morita; Y Horikiri; H Yamahara; T Suzuki; H Yoshino
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

3.  A call to restructure the drug development process: government over-regulation and non-innovative late stage (Phase III) clinical trials are major obstacles to advances in health care.

Authors:  Thomas C Jones
Journal:  Sci Eng Ethics       Date:  2005-10       Impact factor: 3.525

4.  A large-scale process to produce microencapsulated proteins.

Authors:  P Herbert; K Murphy; O Johnson; N Dong; W Jaworowicz; M A Tracy; J L Cleland; S D Putney
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.